Analysts’ Opinions Are Mixed on These Real Estate Stocks: National Health Investors (NHI), Realty Income (O) and RLJ Lodging (RLJ)
Analysts have been eager to weigh in on the Real Estate sector with new ratings on National Health Investors (NHI – Research Report), Realty Income (O – Research Report) and RLJ Lodging (RLJ – Research Report).
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
National Health Investors (NHI)
In a report released today, Michael Lewis from Truist Financial maintained a Buy rating on National Health Investors. The company’s shares closed last Thursday at $87.68.
According to TipRanks.com, Lewis is a 5-star analyst with an average return of
National Health Investors has an analyst consensus of Moderate Buy, with a price target consensus of $85.00, representing a -3.7% downside. In a report issued on February 23, BMO Capital also maintained a Buy rating on the stock with a $90.00 price target.
See the top stocks recommended by analysts >>
Realty Income (O)
In a report released today, Richard Anderson from Cantor Fitzgerald maintained a Hold rating on Realty Income, with a price target of $68.00. The company’s shares closed last Thursday at $66.60.
According to TipRanks.com, Anderson is a 4-star analyst with an average return of
Currently, the analyst consensus on Realty Income is a Moderate Buy with an average price target of $64.96, representing a -1.8% downside. In a report issued on February 25, TipRanks – OpenAI also downgraded the stock to Hold with a $72.00 price target.
RLJ Lodging (RLJ)
In a report released today, Gregory Miller from Truist Financial maintained a Hold rating on RLJ Lodging. The company’s shares closed last Thursday at $8.29, close to its 52-week low of $7.98.
According to TipRanks.com, Miller is a 5-star analyst with an average return of
Currently, the analyst consensus on RLJ Lodging is a Moderate Sell with an average price target of $7.50.
